Cite

HARVARD Citation

    Zhu, J. et al. (2018). Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond. Journal for immunotherapy of cancer. 6 (1), p. . [Online]. 
  
Back to record